US News

Trump allowed the use of foreign vaccines against coronavirus in the US

Trump allowed the use of foreign vaccines against coronavirus in the US

151

US President Donald Trump has allowed the use of foreign vaccines against coronavirus in the country. This was told by the press secretary of the White House Kayleigh Makinani

Europe News

France will not purchase the coronavirus vaccine through the COVAX program

France will not purchase the coronavirus vaccine through the COVAX program

70

France does not plan to use the international COVAX mechanism, designed to provide all states with future coronavirus vaccines on an equitable basis, in order to receive doses of drugs

US News

Trump called the timing of vaccination in the United States from COVID-19

Trump called the timing of vaccination in the United States from COVID-19

127

Donald Trump announced a massive coronavirus vaccination in the US in October 2020. By the end of the year, the United States will be ready to provide up to 100 million doses of the vaccine

US News

Trump expects COVID-19 vaccine in a month

Trump expects COVID-19 vaccine in a month

70

US President Donald Trump said the coronavirus vaccine could be ready by mid-October. The American leader is confident that an effective and safe drug will be ready in the near future

World News

The coronavirus vaccine caused an adverse reaction

The coronavirus vaccine caused an adverse reaction

111

In the USA, trials of the coronavirus vaccine SARS-CoV-2, developed by AstraZeneca and Oxford University, were temporarily stopped due to a possible adverse reaction in one of the patients

US News

Trump Says American COVID-19 Vaccine Coming Very Soon

Trump Says American COVID-19 Vaccine Coming Very Soon

94

According to US President Donald Trump, the American vaccine against coronavirus infection will be prepared in the near future

World News

COVID vaccine development needs $35 billion — UN

COVID vaccine development needs $35 billion — UN

103

The international community should commit $35 billion to accelerate research and development of tests and vaccines for the COVID-19 coronavirus